AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Oramed Pharmaceuticals Inc.

Director's Dealing Jan 12, 2022

6965_rns_2022-01-12_96a92d30-fd12-4c54-b825-18c8c48971c6.pdf

Director's Dealing

Open in Viewer

Opens in native device viewer

SEC Form 3

FORM 3 UNITED STATES SECURITIES AND EXCHANGE

COMMISSION Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB Number: 3235- 0104 Estimated average burden 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person*
Derovan Netanel
2. Date of Event
Requiring Statement
(Month/Day/Year)
01/09/2022
3. Issuer Name and Ticker or Trading Symbol
ORAMED PHARMACEUTICALS INC.
[ ORMP ]
(Last) (First)
(Middle)
1185 AVENUE OF THE
AMERICAS, THIRD FLOOR
NY
10036
4. Relationship of Reporting Person(s) to
Issuer
(Check all applicable)
Director
10% Owner
5. If Amendment, Date of Original
Filed (Month/Day/Year)
(Street)
NEW
YORK,
Officer (give
X
title below)
Chief Legal Officer
Other (specify
below)
6. Individual or Joint/Group Filing
(Check Applicable Line)
Form filed by One Reporting
X
Person
Form filed by More than One
Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities
Beneficially Owned (Instr.
3. Ownership
Form: Direct
(D) or Indirect
(I) (Instr. 5)
4. Nature of Indirect Beneficial
Ownership (Instr. 5)
4)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and
Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities
Underlying Derivative Security
(Instr. 4)
4.
Conversion
or Exercise
Price of
5.
Ownership
Form:
Direct (D)
6. Nature of
Indirect Beneficial
Ownership (Instr.
5)

Explanation of Responses:

No securities are beneficially owned.

/s/ Netanel Derovan 01/11/2022

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

OMB APPROVAL

hours per response:

Talk to a Data Expert

Have a question? We'll get back to you promptly.